enarodustat 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definitionDrug idCAS RN
hypoxia inducible factor (HIF) prolyl hydroxylase inhibitors 5427 1262132-81-9

Description:

MoleculeDescription

Molfile Inchi Smiles

Synonyms:

  • enarodustat
  • enaroy
  • JTZ-951
Enarodustat is an orally active inhibitor of hypoxia inducible factor-proly hydroxylase (HIF-PH) being developed for the treatment of anaemia associated with chronic kidney disease (CKD).
  • Molecular weight: 340.34
  • Formula: C17H16N4O4
  • CLOGP: 0.94
  • LIPINSKI: 0
  • HAC: 8
  • HDO: 4
  • TPSA: 116.82
  • ALOGS: -3.29
  • ROTB: 6

Drug dosage:

None

ADMET properties:

None

Approvals:

DateAgencyCompanyOrphan
Sept. 25, 2020 PMDA Japan Tabacco

FDA Adverse Event Reporting System (Female)

None

FDA Adverse Event Reporting System (Male)

None

FDA Adverse Event Reporting System (Geriatric)

None

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

None

Drug Use | Suggest Off label Use Form| |View source of the data|

DiseaseRelationSNOMED_IDDOID
Anemia of renal disease indication 234348004
Anemia in chronic kidney disease indication 707323002




🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

None

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

TargetClassPharosUniProtActionTypeActivity value
(-log[M])
Mechanism
action
Bioact sourceMoA source
Egl nine homolog 1 Enzyme INHIBITOR Ki 7.80 SCIENTIFIC LITERATURE SCIENTIFIC LITERATURE
Egl nine homolog 2 Enzyme INHIBITOR Ki 7.21 SCIENTIFIC LITERATURE SCIENTIFIC LITERATURE
Egl nine homolog 3 Enzyme INHIBITOR Ki 7 SCIENTIFIC LITERATURE SCIENTIFIC LITERATURE

External reference:

IDSource
D11523 KEGG_DRUG
JSK7TUA223 UNII
C5139933 UMLSCUI
CHEMBL4297619 ChEMBL_ID
50899324 PUBCHEM_CID
DB14985 DRUGBANK_ID
11828 IUPHAR_LIGAND_ID
C000656654 MESH_SUPPLEMENTAL_RECORD_UI
10572 INN_ID

Pharmaceutical products:

None